Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy

E. Brusamolino, M. Lazzarino, E. Orlandi, A. Canevari, E. Morra, G. Castelli, E. P. Alessandrino, G. Pagnucco, C. Astori, A. Livraghi, F. Corbella, P. Franchini, C. Bernasconi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Controversy still exists over the optimal management of early-stage Hodgkin's disease (HD); presentation features may have a different prognostic impact according to initial therapy, and long-term toxicity must be fully evaluated. Patients and methods: This study included 164 patients with stage IA-IIA HD treated with radiotherapy (RT) alone or combined radio- and chemotherapy (CT) according to presenting features and their attendant prognostic significance. The RT group included 88 patients with favorable prognostic features; the combined modality group included 76 patients with one or more unfavorable features. In the RT group, 85% of patients received extended-mantle or STNI; in the combined modality group, RT consisted of mantle (49%), extended mantle- (37%), and involved-field irradiation (14%); CT consisted of 6 cycles of MOPP before 1984; 3 cycles of ABVD were substituted for thereafter. Results: Complete remission was obtained in 94% and 99% of patients of the RT and combined modality groups, respectively. The 10-year actuarial relapse-free survival (RFS) in the RT group was 62% and was influenced by stage (p = 0.04) and histology (p = 0.01); in the combined modality group, RFS was 88% and was influenced by the presence of bulky disease. Overall survival and tumor mortality between the therapy groups were comparable. RT-related toxicity consisted of mediastinal fibrosis (8 cases), myelitis (3), hypothyroidism (2); other long-term events included 2 cases of acute leukemia in the combined MOPP and RT group. Altogether, 8 of 20 patients who died were in their first complete remission. Conclusions: In stage IA-IIA HD, the combined modality therapy reduced the risk of relapse compared to radiation alone; long-term toxicity of RT was not negligible and relapses could occur late.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalAnnals of Oncology
Volume5
Issue numberSUPPL. 2
Publication statusPublished - 1994

Fingerprint

Hodgkin Disease
Radiotherapy
Drug Therapy
Recurrence
Survival
Myelitis
Combined Modality Therapy
Group Psychotherapy
Hypothyroidism
Histology
Leukemia
Radiation
Mortality

Keywords

  • combined modality
  • Hodgkin's disease
  • initial stages
  • radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Brusamolino, E., Lazzarino, M., Orlandi, E., Canevari, A., Morra, E., Castelli, G., ... Bernasconi, C. (1994). Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Annals of Oncology, 5(SUPPL. 2), 101-106.

Early-stage Hodgkin's disease : Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. / Brusamolino, E.; Lazzarino, M.; Orlandi, E.; Canevari, A.; Morra, E.; Castelli, G.; Alessandrino, E. P.; Pagnucco, G.; Astori, C.; Livraghi, A.; Corbella, F.; Franchini, P.; Bernasconi, C.

In: Annals of Oncology, Vol. 5, No. SUPPL. 2, 1994, p. 101-106.

Research output: Contribution to journalArticle

Brusamolino, E, Lazzarino, M, Orlandi, E, Canevari, A, Morra, E, Castelli, G, Alessandrino, EP, Pagnucco, G, Astori, C, Livraghi, A, Corbella, F, Franchini, P & Bernasconi, C 1994, 'Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy', Annals of Oncology, vol. 5, no. SUPPL. 2, pp. 101-106.
Brusamolino E, Lazzarino M, Orlandi E, Canevari A, Morra E, Castelli G et al. Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Annals of Oncology. 1994;5(SUPPL. 2):101-106.
Brusamolino, E. ; Lazzarino, M. ; Orlandi, E. ; Canevari, A. ; Morra, E. ; Castelli, G. ; Alessandrino, E. P. ; Pagnucco, G. ; Astori, C. ; Livraghi, A. ; Corbella, F. ; Franchini, P. ; Bernasconi, C. / Early-stage Hodgkin's disease : Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. In: Annals of Oncology. 1994 ; Vol. 5, No. SUPPL. 2. pp. 101-106.
@article{801fb23d75524e1e83ae4e3bd0d91765,
title = "Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy",
abstract = "Background: Controversy still exists over the optimal management of early-stage Hodgkin's disease (HD); presentation features may have a different prognostic impact according to initial therapy, and long-term toxicity must be fully evaluated. Patients and methods: This study included 164 patients with stage IA-IIA HD treated with radiotherapy (RT) alone or combined radio- and chemotherapy (CT) according to presenting features and their attendant prognostic significance. The RT group included 88 patients with favorable prognostic features; the combined modality group included 76 patients with one or more unfavorable features. In the RT group, 85{\%} of patients received extended-mantle or STNI; in the combined modality group, RT consisted of mantle (49{\%}), extended mantle- (37{\%}), and involved-field irradiation (14{\%}); CT consisted of 6 cycles of MOPP before 1984; 3 cycles of ABVD were substituted for thereafter. Results: Complete remission was obtained in 94{\%} and 99{\%} of patients of the RT and combined modality groups, respectively. The 10-year actuarial relapse-free survival (RFS) in the RT group was 62{\%} and was influenced by stage (p = 0.04) and histology (p = 0.01); in the combined modality group, RFS was 88{\%} and was influenced by the presence of bulky disease. Overall survival and tumor mortality between the therapy groups were comparable. RT-related toxicity consisted of mediastinal fibrosis (8 cases), myelitis (3), hypothyroidism (2); other long-term events included 2 cases of acute leukemia in the combined MOPP and RT group. Altogether, 8 of 20 patients who died were in their first complete remission. Conclusions: In stage IA-IIA HD, the combined modality therapy reduced the risk of relapse compared to radiation alone; long-term toxicity of RT was not negligible and relapses could occur late.",
keywords = "combined modality, Hodgkin's disease, initial stages, radiotherapy",
author = "E. Brusamolino and M. Lazzarino and E. Orlandi and A. Canevari and E. Morra and G. Castelli and Alessandrino, {E. P.} and G. Pagnucco and C. Astori and A. Livraghi and F. Corbella and P. Franchini and C. Bernasconi",
year = "1994",
language = "English",
volume = "5",
pages = "101--106",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Early-stage Hodgkin's disease

T2 - Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy

AU - Brusamolino, E.

AU - Lazzarino, M.

AU - Orlandi, E.

AU - Canevari, A.

AU - Morra, E.

AU - Castelli, G.

AU - Alessandrino, E. P.

AU - Pagnucco, G.

AU - Astori, C.

AU - Livraghi, A.

AU - Corbella, F.

AU - Franchini, P.

AU - Bernasconi, C.

PY - 1994

Y1 - 1994

N2 - Background: Controversy still exists over the optimal management of early-stage Hodgkin's disease (HD); presentation features may have a different prognostic impact according to initial therapy, and long-term toxicity must be fully evaluated. Patients and methods: This study included 164 patients with stage IA-IIA HD treated with radiotherapy (RT) alone or combined radio- and chemotherapy (CT) according to presenting features and their attendant prognostic significance. The RT group included 88 patients with favorable prognostic features; the combined modality group included 76 patients with one or more unfavorable features. In the RT group, 85% of patients received extended-mantle or STNI; in the combined modality group, RT consisted of mantle (49%), extended mantle- (37%), and involved-field irradiation (14%); CT consisted of 6 cycles of MOPP before 1984; 3 cycles of ABVD were substituted for thereafter. Results: Complete remission was obtained in 94% and 99% of patients of the RT and combined modality groups, respectively. The 10-year actuarial relapse-free survival (RFS) in the RT group was 62% and was influenced by stage (p = 0.04) and histology (p = 0.01); in the combined modality group, RFS was 88% and was influenced by the presence of bulky disease. Overall survival and tumor mortality between the therapy groups were comparable. RT-related toxicity consisted of mediastinal fibrosis (8 cases), myelitis (3), hypothyroidism (2); other long-term events included 2 cases of acute leukemia in the combined MOPP and RT group. Altogether, 8 of 20 patients who died were in their first complete remission. Conclusions: In stage IA-IIA HD, the combined modality therapy reduced the risk of relapse compared to radiation alone; long-term toxicity of RT was not negligible and relapses could occur late.

AB - Background: Controversy still exists over the optimal management of early-stage Hodgkin's disease (HD); presentation features may have a different prognostic impact according to initial therapy, and long-term toxicity must be fully evaluated. Patients and methods: This study included 164 patients with stage IA-IIA HD treated with radiotherapy (RT) alone or combined radio- and chemotherapy (CT) according to presenting features and their attendant prognostic significance. The RT group included 88 patients with favorable prognostic features; the combined modality group included 76 patients with one or more unfavorable features. In the RT group, 85% of patients received extended-mantle or STNI; in the combined modality group, RT consisted of mantle (49%), extended mantle- (37%), and involved-field irradiation (14%); CT consisted of 6 cycles of MOPP before 1984; 3 cycles of ABVD were substituted for thereafter. Results: Complete remission was obtained in 94% and 99% of patients of the RT and combined modality groups, respectively. The 10-year actuarial relapse-free survival (RFS) in the RT group was 62% and was influenced by stage (p = 0.04) and histology (p = 0.01); in the combined modality group, RFS was 88% and was influenced by the presence of bulky disease. Overall survival and tumor mortality between the therapy groups were comparable. RT-related toxicity consisted of mediastinal fibrosis (8 cases), myelitis (3), hypothyroidism (2); other long-term events included 2 cases of acute leukemia in the combined MOPP and RT group. Altogether, 8 of 20 patients who died were in their first complete remission. Conclusions: In stage IA-IIA HD, the combined modality therapy reduced the risk of relapse compared to radiation alone; long-term toxicity of RT was not negligible and relapses could occur late.

KW - combined modality

KW - Hodgkin's disease

KW - initial stages

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0028123338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028123338&partnerID=8YFLogxK

M3 - Article

C2 - 7515642

AN - SCOPUS:0028123338

VL - 5

SP - 101

EP - 106

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 2

ER -